{"version":"1.0","type":"link","title":"Efficacy and safety of pyrotinib-based regimens in patients with HER2-positive stage III/IV breast cancer: a real-world retrospective study in China.","author_name":"Zhi L 외","author_url":"https://prs-insight.online/author/Zhi%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/89689","thumbnail_width":1200,"thumbnail_height":630}